New Anaerobic Activity Index Quantifies Anti-Anaerobic Antibiotic Exposure
This study introduces a granular, susceptibility-based scoring metric that lets stewardship teams and researchers move beyond binary anti-anaerobic classification when studying microbiome-mediated harms.
📅 Journal publication: Aug 4, 2026·Last updated: Aug 4, 2026
A new index ranks antibiotics by anaerobic activity exposure.
Antibiotics with anaerobic activity can lead to unfavorable outcomes in burn patients, necessitating a reliable way to quantify exposure. The Anaerobic Activity Index (AAI) ranks antibiotics based on anaerobic activity, with meropenem having the highest score. Higher AAI quartiles were linked to worse outcomes (OR: 2.90; 95% CI: 1.65-5.08). The AAI provides a tool to evaluate antibiotic effects on anaerobic bacteria, though it requires updates with new data and excludes some antibiotics due to insufficient data. The Anaerobic Activity Index helps quantify exposure to anaerobic-active antibiotics, potentially influencing patient outcomes.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Free account, no credit card. Includes 1 full deep analysis every month.
Authors:Mackow NA, Komarow L, Napravnik S, Andermann TM, Bartelt L, DiBiase LM, Williams B, Williams FN, Young VB, Aronoff DM, Weber DJ, Chanderraj R, van Duin D
Citation:Mackow NA, Komarow L, Napravnik S, et al. Development and Application of an Anaerobic Activity Index. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2026. doi:10.1093/cid/ciag470